Broad-spectrum antiviral activity of ebselen

Kunlakanya Jitobaom, Usa Boonyuen, Chompunuch Boonarkart, Thanyaporn Sirihongthong, Prasert Auewarakul · 2025

Read Broad-spectrum antiviral activity of ebselen by Kunlakanya Jitobaom, Usa Boonyuen, Chompunuch Boonarkart, Thanyaporn Sirihongthong, Prasert Auewarakul (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12749127.txt.

Description

Jitobaom and four co-authors reported this study in twenty twenty-five on a drug with wide antiviral reach. Broad drugs that work against many viruses are prized for pandemic readiness. The team tested ebselen, a lab-made compound that contains selenium. It was checked against dengue, Zika, chikungunya, flu, and a gut virus.

Ebselen blocked all five viruses in the lab. The authors traced much of its effect to one host enzyme, IMPA, which helps make a fat-like molecule that viruses need. Silencing the enzyme cut virus output. Adding back the missing molecule weakened the drug's effect. A second drug that blocks the same enzyme also worked broadly. The team names IMPA as a promising target for future antiviral drugs.

Catalog record

CREATORKunlakanya Jitobaom, Usa Boonyuen, Chompunuch Boonarkart, Thanyaporn Sirihongthong, Prasert Auewarakul
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE47 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12749127

Browse the full library · About the Tower of Babel